The World Health Organization (WHO) has validated Eritrea’s elimination of trachoma as a public health problem, making it the 11th country in Africa and the 34th globally to achieve the milestone.
WHO Director-General Dr Tedros Ghebreyesus congratulated Eritrea’s government and people in a statement on Monday, describing the achievement as a victory for affected communities following two decades of sustained national efforts.
“The milestone demonstrates what sustained national commitment can achieve in eliminating neglected tropical diseases and protecting vulnerable populations from preventable blindness,” he said, commending the country’s long-running public health campaign.
Eritrea achieved the milestone by implementing WHO’s SAFE strategy, which combines surgery for advanced trachoma, antibiotics, facial cleanliness and environmental improvements, particularly better access to clean water and basic sanitation.
Ghebreyesus said Eritrea conducted baseline surveys between 2006 and 2020 before gradually expanding interventions across affected communities, particularly remote rural areas with limited healthcare access and inadequate sanitation facilities.
WHO Regional Director for Africa Dr Mohamed Janabi said Eritrea’s achievement reflected sustained political commitment, community leadership and strong partnerships in tackling neglected tropical diseases across the country and the region.
He said the milestone brought Africa closer to ending the suffering caused by neglected tropical diseases and offered hope to other countries pursuing trachoma elimination through coordinated public health action.
“Eritrea’s programme adopted community-led sanitation initiatives and digital tools for data collection and mapping, enabling health workers to identify affected communities and direct interventions to hard-to-reach populations,” he said.
Janabi said the country surveyed all 58 sub-zobas, its second-level administrative areas, and expanded interventions wherever trachoma was endemic. The programme also relied largely on donated oral azithromycin antibiotics to prevent and control infections.
WHO Representative to Eritrea Dr Mary Stephen attributed the achievement to national leadership, community ownership and collaboration involving the Ministry of Health, partners and healthcare workers throughout the elimination campaign.
Stephen said WHO would continue supporting the government and its partners to sustain the gains, ensuring communities remained protected against a possible resurgence of the disease.
“Trachoma, caused by the bacterium Chlamydia trachomatis, is the world’s leading infectious cause of blindness and spreads through contact with discharge from infected people’s eyes and noses,” she said.
“Repeated infections can cause scarring of the inner eyelid, turning eyelashes inward and damaging the eye, potentially resulting in irreversible blindness if left untreated,” she added.
Stephen said global efforts had reduced the population requiring trachoma interventions from an estimated 1.5 billion in 2002 to fewer than 100 million by November 2025, according to WHO data.
However, about 92 million people remained at risk in trachoma-endemic areas as of March 2026, with the disease still constituting a public health problem in at least 29 countries.
In 2025, WHO data showed that 98,829 people received surgery for advanced trachoma, while 47.4 million received antibiotics to prevent and control the disease.
“Eritrea is also the 66th country globally and the 23rd in WHO’s African Region to have eliminated at least one neglected tropical disease,” Stephen said.
Editorial note: I made a few important style adjustments:
Removed unnecessary repetitions such as “across the country”, “nationwide” and “nationally”.
Changed some indirect expressions to clearer, more concise language.
Improved transitions between paragraphs.
Standardised the reporting of figures and geographical rankings.
Changed some past-tense descriptions to present tense where they refer to WHO strategies or established facts.
Fact-checking note: The dates and statistics have been retained as supplied. However, the reference to November 2025 and March 2026 should be checked against the original WHO report before publication, particularly if the article is being published now.

